local_hospital

Zealand University Hospital

Address
Lykkebaekvej 1., 4600 Køge, Denmark

Analytical, Diagnostic and Therapeutic Techniques and Equipment – Anesthesia and Analgesia

The department explores advanced anesthesia and analgesia methods, especially for orthopedic procedures. Recent work assesses the impact of ultrasound‑guided brachial plexus nerve block in patients with distal radius fracture undergoing closed reduction, aiming to improve pain control while minimizing side effects.

  • Regional anesthesia techniques for fracture management
  • Imaging‑assisted nerve block procedures
  • Safety and efficacy comparison with standard care
  • Integration of analgesic protocols into postoperative pathways

Zealand University Hospital’s surgical team collaborates with anesthesiology specialists to integrate imaging technologies into routine care.

Diseases – Digestive System Diseases

Research targets gastrointestinal malignancies, focusing on localised dMMR colon cancer. A key study evaluates the proportion of patients achieving a clinical complete response after treatment with pembrolizumab, seeking to refine non‑surgical management options.

  • Immunotherapy outcomes in mismatch repair‑deficient tumors
  • Biomarker identification for response prediction
  • Evaluation of organ‑preserving treatment strategies
  • Long‑term surveillance of complete responders

The Department of Surgery leads the effort, leveraging the hospital’s oncology expertise.

Diseases – Musculoskeletal Diseases

Clinical investigations address acute bone injuries, with emphasis on distal radius fracture care. Trials compare innovative regional anesthesia techniques to conventional analgesia during closed reduction, aiming to accelerate recovery and reduce opioid use.

  • Pain management strategies for fracture reduction
  • Functional outcome assessment after nerve block
  • Opioid‑sparing protocols in orthopedic surgery
  • Early mobilization and rehabilitation pathways

The site’s orthopedic surgeons at Zealand University Hospital coordinate patient enrollment and outcome monitoring.

Diseases – Neoplasms

Oncologic programs examine immune‑based therapies across tumor types. Studies measure clinical complete response rates and explore predictive biomarkers to personalize treatment strategies.

  • Immune checkpoint inhibitor efficacy in solid tumors
  • Molecular profiling for therapy selection
  • Assessment of response durability and quality of life
  • Collaborative multidisciplinary cancer care pathways

Multidisciplinary teams at the hospital integrate surgery, pathology, and medical oncology to advance cancer care.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
3
IMPs

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
2
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 111 other sites in Denmark

description
Trial volume
2
Outperforms 43% of sites
public
Therapeutic diversity
4areas
Outperforms 64% of sites
groups
Sponsor diversity
2sponsors
Outperforms 47% of sites

Therapeutic Area Benchmark — Denmark

Select a therapeutic area to compare against other sites in Denmark.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Denmark

Market Share

Country: Denmark

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Zealand University Hospital

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Ultrasound-Guided Brachial Plexus Nerve Block with Epinephrine and Lidocaine Hydrochloride for Closed Reduction of Distal Radius Fracture in AdultsRegion HovedstadenPhase IIIRecruitingDec 2024

IMP list

lock Showing 1 of 3 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Epinephrine1Unknown2024-12-102024-12-10

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.